Nu-Med Plus, Inc. NUMD
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 117.31% | -29.41% | 5.38% | -41.95% | -35.00% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 117.31% | -29.41% | 5.38% | -41.95% | -35.00% |
| Operating Income | -117.31% | 29.41% | -5.38% | 41.95% | 35.00% |
| Income Before Tax | 268.38% | 20.10% | -18.87% | 35.83% | 32.37% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 268.38% | 20.10% | -18.87% | 35.83% | 32.37% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 268.38% | 20.10% | -18.87% | 35.83% | 32.37% |
| EBIT | -117.31% | 29.41% | -5.38% | 41.95% | 35.00% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 300.00% | 0.00% | -100.00% | 50.00% | 50.00% |
| Normalized Basic EPS | 200.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS Diluted | 300.00% | 0.00% | -100.00% | 50.00% | 50.00% |
| Normalized Diluted EPS | 200.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |